Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Comprehensive, up-to-date, evidence-based COVID19 drug-drug interaction resource, freely available to healthcare workers, patients and...

Comprehensive, up-to-date, evidence-based COVID19 drug-drug interaction resource, freely available to healthcare workers, patients and...

Comprehensive, up-to-date, evidence-based COVID19 drug-drug interaction resource, freely available to healthcare workers, patients and...

Comprehensive, up-to-date, evidence-based COVID19 drug-drug interaction resource, freely available to healthcare workers, patients and...

Comprehensive, up-to-date, evidence-based COVID19 drug-drug interaction resource, freely available to healthcare workers, patients and...

Comprehensive, up-to-date, evidence-based COVID19 drug-drug interaction resource, freely available to healthcare workers, patients and...

Comprehensive, up-to-date, evidence-based COVID19 drug-drug interaction resource, freely available to healthcare workers, patients and...

Detailed recommendations for interactions with experimental COVID-19 therapies. UPDATED – Drugs and interactions reviewed for known or possible QT/TdP risk (as indicated on crediblemeds.org)....

Detailed recommendations for interactions with experimental COVID-19 therapies. UPDATED – Atazanavir and tocilizumab added as new COVID-therapies; anticonvulsants and antifungals added as new comedications....

  • 1241747620256718848 Profile photo of Madelyn

    The Liverpool Drug Interaction Group (Univ UK), in collaboration with the University Hospital of Basel (Switzerland) and Radboud UMC (NL), have produced various materials in PDF format to aid the use of experimental agents in the treatment of COVID-19.https://t.co/vEN2vq3lOH - view on twitter